Bicycle Therapeutics (BCYC) Receivables (2019 - 2025)
Historic Receivables for Bicycle Therapeutics (BCYC) over the last 7 years, with Q1 2025 value amounting to $46.4 million.
- Bicycle Therapeutics' Receivables changed N/A to $46.4 million in Q1 2025 from the same period last year, while for Mar 2025 it was $46.4 million, marking a year-over-year change of. This contributed to the annual value of $35.7 million for FY2024, which is 4831.32% up from last year.
- Per Bicycle Therapeutics' latest filing, its Receivables stood at $46.4 million for Q1 2025.
- In the past 5 years, Bicycle Therapeutics' Receivables registered a high of $76.5 million during Q1 2023, and its lowest value of $11.9 million during Q4 2021.
- In the last 5 years, Bicycle Therapeutics' Receivables had a median value of $25.2 million in 2022 and averaged $32.8 million.
- Per our database at Business Quant, Bicycle Therapeutics' Receivables soared by 38958.28% in 2023 and then plummeted by 1948.8% in 2024.
- Quarter analysis of 5 years shows Bicycle Therapeutics' Receivables stood at $11.9 million in 2021, then skyrocketed by 78.06% to $21.2 million in 2022, then rose by 13.35% to $24.0 million in 2023, then skyrocketed by 48.31% to $35.7 million in 2024, then soared by 30.07% to $46.4 million in 2025.
- Its Receivables stands at $46.4 million for Q1 2025, versus $35.7 million for Q4 2024 and $46.7 million for Q2 2024.